The angiotensin receptor antagonist, irbesartan, reduces renal injury in experimental chronic renal failure

Kidney International, Supplement

Volumn 50, Issue 57, 1996, Pages

  Ziai, F ^a   Ots, M ^a   Provoost, A P ^a   Troy, J L ^a   Rennke, H G ^a   Brenner, B M ^a   Mackenzie, H S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ENALAPRIL; IRBESARTAN; ANGIOTENSIN RECEPTOR; ANTIHYPERTENSIVE AGENT; BIPHENYL DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TETRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; CONTROLLED STUDY; GLOMERULOSCLEROSIS; KIDNEY INJURY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; ANIMAL; ARTICLE; BLOOD PRESSURE; DRUG ANTAGONISM; DRUG EFFECT; GLOMERULUS; NEPHRECTOMY; PATHOPHYSIOLOGY; PROTEINURIA; SPONTANEOUSLY HYPERTENSIVE RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; BIPHENYL COMPOUNDS; BLOOD PRESSURE; ENALAPRIL; KIDNEY FAILURE, CHRONIC; KIDNEY GLOMERULUS; NEPHRECTOMY; PROTEINURIA; RATS; RATS, INBRED SHR; RECEPTORS, ANGIOTENSIN; TETRAZOLES;

EID: 0029958395     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)